NDASUBCUTANEOUSSOLUTION
Approved
Sep 2018
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
4
Clinical Trials (4)
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
Started Jun 2016
Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism
Started Jul 2015
Pharmacokinetic Study of Subcutaneous Testosterone Enanthate
Started Sep 2014
Pharmacokinetic Study of Testosterone Enanthate
Started Sep 2013
Loss of Exclusivity
LOE Date
Aug 30, 2038
152 months away
Patent Expiry
Aug 30, 2038